OR YEHUDA, Israel, March 7, 2023 /PRNewswire/ — Restore Medical Ltd, a privately held medical device company, has successfully completed enrollment of the First In Human clinical study with its CONTRABAND™ device. The world’s first and only Pulmonary Artery Banding (PAB) transcatheter implant is designed to treat heart failure with reduced ejection fraction (HFrEF) and […]
Tag: ContraBand
Restore Medical Announces First in Human Trial for Treatment of Heart Failure in Patients
ContraBand™ technology helps restore the heart’s functionality and may significantly improve patients’ quality of life OR YEHUDA, Israel, Dec. 7, 2021 /PRNewswire/ — Restore Medical Ltd., a clinical-stage MedTech company developing cardiac implants for the treatment of congestive heart failure (CHF), today announced promising preliminary results of the First-in-Human clinical trial of ContraBand™, a breakthrough treatment […]
Recent
SIS Medical AG Welcomes the Results of the VICTORY Trial Demonstrating Non-inferiority of OPN NC to Intravascular Lithotrispy (IVL) for Lesion Preparation and Stent Expansion in Severely Calcified Lesions
Late-Breaking Clinical Trial Results Announced at VIVA 2025
Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
Popular
- No commented posts yet